Tacrolimus causes reduced GLI1 expression and phenotypic changes in the TE 354.T basal cell carcinoma cell line.
Di Gennaro
P
P
Sestini
R
R
Bacci
S
S
Pacini
A
A
Pinzani
P
P
Domenici
L
L
Toscano
A
A
Massi
D
D
Carli
P
P
Genuardi
M
M
Romagnoli
P
P
D001779:Blood Coagulation Factors / Q000187:drug effects / Q000378:metabolism; D002280:Basal Cell Carcinoma / Q000378:metabolism* / Q000473:pathology; D045744:Cell Line, Tumor; D015870:Gene Expression / Q000187:drug effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D000072079:Patched Receptors; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000037:antagonists & inhibitors / Q000378:metabolism; D016601:RNA-Binding Proteins; D011956:Receptors, Cell Surface / Q000187:drug effects / Q000378:metabolism; D043562:Receptors, G-Protein-Coupled / Q000187:drug effects / Q000378:metabolism; D012269:Ribosomal Proteins; D000072086:Smoothened Receptor; D016559:Tacrolimus / Q000494:pharmacology*; D014157:Transcription Factors / Q000037:antagonists & inhibitors* / Q000378:metabolism; D000071676:Zinc Finger Protein GLI1
D001779:Blood Coagulation Factors; C400551:GLI1 protein, human; D007166:Immunosuppressive Agents; D000072079:Patched Receptors; D019253:Proto-Oncogene Proteins c-bcl-2; D016601:RNA-Binding Proteins; C104946:RPL29 protein, human; D011956:Receptors, Cell Surface; D043562:Receptors, G-Protein-Coupled; D012269:Ribosomal Proteins; C491023:SMO protein, human; D000072086:Smoothened Receptor; D014157:Transcription Factors; D000071676:Zinc Finger Protein GLI1; D016559:Tacrolimus